tetano
Editor, Senior Moderator
Case Rep Infect Dis
. 2020 Sep 5;2020:8814249.
doi: 10.1155/2020/8814249. eCollection 2020.
Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs
Masakiyo Yatomi[SUP] 1 [/SUP], Tomonori Takazawa[SUP] 2 [/SUP], Kunio Yanagisawa[SUP] 3 [/SUP], Masafumi Kanamoto[SUP] 2 [/SUP], Yusuke Matsui[SUP] 2 [/SUP], Hiroyuki Tsukagoshi[SUP] 4 [/SUP], Nobuhiro Saruki[SUP] 4 [/SUP], Shigeru Saito[SUP] 2 [/SUP], Yutaka Tokue[SUP] 3 [/SUP], Toshitaka Maeno[SUP] 1 [/SUP]
Affiliations
Abstract
Although a variety of existing drugs are being tested for patients with coronavirus disease 2019 (COVID-19), no efficacious treatment has been found so far, particularly for severe cases. We report successful recovery in an elderly patient with severe pneumonia requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Despite administration of multiple antiviral drugs, including lopinavir/ritonavir, chloroquine, and favipiravir, the patient's condition did not improve. However, after administration of another antiviral drug, remdesivir, we were able to terminate invasive interventions, including ECMO, and subsequently obtained negative polymerase chain reaction results. Although further validation is needed, remdesivir might be effective in treating COVID-19.
. 2020 Sep 5;2020:8814249.
doi: 10.1155/2020/8814249. eCollection 2020.
Improvement of Severe COVID-19 in an Elderly Man by Sequential Use of Antiviral Drugs
Masakiyo Yatomi[SUP] 1 [/SUP], Tomonori Takazawa[SUP] 2 [/SUP], Kunio Yanagisawa[SUP] 3 [/SUP], Masafumi Kanamoto[SUP] 2 [/SUP], Yusuke Matsui[SUP] 2 [/SUP], Hiroyuki Tsukagoshi[SUP] 4 [/SUP], Nobuhiro Saruki[SUP] 4 [/SUP], Shigeru Saito[SUP] 2 [/SUP], Yutaka Tokue[SUP] 3 [/SUP], Toshitaka Maeno[SUP] 1 [/SUP]
Affiliations
- PMID: 32908736
- PMCID: PMC7475736
- DOI: 10.1155/2020/8814249
Abstract
Although a variety of existing drugs are being tested for patients with coronavirus disease 2019 (COVID-19), no efficacious treatment has been found so far, particularly for severe cases. We report successful recovery in an elderly patient with severe pneumonia requiring mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Despite administration of multiple antiviral drugs, including lopinavir/ritonavir, chloroquine, and favipiravir, the patient's condition did not improve. However, after administration of another antiviral drug, remdesivir, we were able to terminate invasive interventions, including ECMO, and subsequently obtained negative polymerase chain reaction results. Although further validation is needed, remdesivir might be effective in treating COVID-19.